Stay updated on Nivo40 in Relapsed Hodgkins Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Nivo40 in Relapsed Hodgkins Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivo40 in Relapsed Hodgkins Lymphoma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer now displays revision v3.8.0 instead of v3.7.2.
    Difference
    0.2%
    Check dated 2026-11-01T01:44:11.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    A site-wide banner announces NIH’s transition to using “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI) and links to transition updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T01:41:34.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The footer revision identifier was updated from v3.7.1 to v3.7.2 on the page displaying a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T01:25:39.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The site footer revision identifier changed from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T01:51:49.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error with a minimalist layout (and a Home link) along with a revision tag, replacing the previously visible study details and related navigation.
    Difference
    17%
    Check dated 2026-09-20T00:51:51.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    The page shows a new Revision value (v3.6.6) replacing the previous v3.6.5, indicating a small platform update to the page rendering or backend components.
    Difference
    0.1%
    Check dated 2026-08-29T19:42:27.000Z thumbnail image

Stay in the know with updates to Nivo40 in Relapsed Hodgkins Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivo40 in Relapsed Hodgkins Lymphoma Clinical Trial page.